Vello Tougu
Tallinn, Estonia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
α-Lipoic acid: a potential regulator of copper metabolism in Alzheimer's disease.
Journal: Frontiers in molecular biosciences
Published: June 19, 2024
Evaluation of Zn2+- and Cu2+-Binding Affinities of Native Cu,Zn-SOD1 and Its G93A Mutant by LC-ICP MS.
Journal: Molecules (Basel, Switzerland)
Published: April 14, 2022
α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: December 05, 2021
Surface carboxylation or PEGylation decreases CuO nanoparticles' cytotoxicity to human cells in vitro without compromising their antibacterial properties.
Journal: Archives of toxicology
Published: January 31, 2020
Copper(II) partially protects three histidine residues and the N-terminus of amyloid-β peptide from diethyl pyrocarbonate (DEPC) modification.
Journal: FEBS open bio
Published: October 15, 2019
Toxicity of Amyloid-β Peptides Varies Depending on Differentiation Route of SH-SY5Y Cells.
Journal: Journal of Alzheimer's disease : JAD
Published: August 28, 2019
Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent.
Journal: Scientific reports
Published: October 27, 2017
Insulin Fibrillization at Acidic and Physiological pH Values is Controlled by Different Molecular Mechanisms.
Journal: The protein journal
Published: October 24, 2015
Last Updated: 09/26/2026